RVNC - Revance Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RVNC (1479290)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
28 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-11-18
RVNCHollander DavidCMO, Global Therapeutics LeadS - Sale$4.17-3,908104,945-4%-$16,296
2024-04-16
RVNCJordan EricaChief Commercial OfficerS - Sale$3.80-2,392114,864-2%-$9,096
2024-03-18
RVNCSjuts Dustin SPresS - Sale$5.04-9,211167,550-5%-$46,446
2024-03-18
RVNCMoxie DwightCLO, GCS - Sale$5.04-8,125137,815-6%-$40,971
2024-03-18
RVNCSchilke TobinCFOS - Sale$5.04-9,361192,666-5%-$47,204
2024-03-06
RVNCFoley Mark JCEOP - Purchase$6.98+30,0001,126,381+3%+$209,400
M
2023-09-05
RVNCMoxie DwightSVP, GC, SecretaryS - Sale$17.58-34,85344,066-44%-$612,624
2023-08-03
RVNCFoley Mark JCEOS - Sale$22.57-26,279951,288-3%-$593,151
2023-07-03
RVNCSchilke TobinCFOS - Sale$25.04-1,70179,896-2%-$42,593
2023-07-03
RVNCFoley Mark JCEOS - Sale$24.94-26,279977,567-3%-$655,333
D
2023-06-15
RVNCKolaja Carey OconnorDirS - Sale+OE$28.24-2,50016,561-13%-$70,600
2023-06-09
RVNCSjuts Dustin SPresS - Sale$30.82-5,000147,347-3%-$154,096
2023-06-09
RVNCFoley Mark JCEOS - Sale$30.72-31,2791,002,846-3%-$960,928
M
2023-06-01
RVNCSchilke TobinCFOS - Sale$30.64-3,20180,828-4%-$98,070
2023-05-15
RVNCMoxie DwightSVP, GC, SecretaryS - Sale$34.55-21,40169,165-24%-$739,338
2023-05-15
RVNCSchilke TobinCFOS - Sale$34.55-21,40184,029-20%-$739,338
2023-05-15
RVNCFoley Mark JCEOS - Sale$34.55-70,4471,034,125-6%-$2,433,725
2023-05-15
RVNCSjuts Dustin SPresS - Sale$34.55-21,015152,347-12%-$726,003
2023-05-01
RVNCSchilke TobinCFOS - Sale$31.70-3,20163,081-5%-$101,472
2023-04-03
RVNCSchilke TobinCFOS - Sale$32.15-3,20166,282-5%-$102,912
2023-03-09
RVNCMoxie DwightSVP, GC, SecretaryS - Sale$31.59-18,49655,547-25%-$584,220
2023-03-09
RVNCSchilke TobinCFOS - Sale$31.59-18,51773,222-20%-$584,884
2023-03-09
RVNCSjuts Dustin SPresS - Sale$31.59-21,508123,934-15%-$679,358
2023-03-09
RVNCFoley Mark JCEOS - Sale$31.59-70,390934,264-7%-$2,223,360
2023-03-01
RVNCSchilke TobinCFOS - Sale$33.50-3,20149,390-6%-$107,234
D
2023-02-01
RVNCSchilke TobinCFOS - Sale+OE$34.60-3,20154,676-6%-$110,755
2023-01-20
RVNCSchilke TobinCFOS - Sale$31.00-1,00057,877-2%-$31,000
2023-01-09
RVNCSchilke TobinCFOS - Sale$27.16-3,70158,877-6%-$100,525

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top